Nuveen’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Nuveen’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-39,571	Closed	-$728K	–	3420
2020 Q4	$728K	Buy	39,571 +272	+0.7%	+$4.96K	﹤0.01%	2916
2020 Q3	$721K	Buy	39,299 +7,400	+23%	+$124K	﹤0.01%	2821
2020 Q2	$478K	Sell	31,899 -280	-0.9%	-$4K	﹤0.01%	2919
2020 Q1	$509K	Sell	32,179 -293	-0.9%	-$4.74K	﹤0.01%	2767
2019 Q4	$527K	Sell	32,472 -79	-0.2%	-$1.32K	﹤0.01%	2898
2019 Q3	$484K	Sell	32,551 -2,695	-8%	-$36.3K	﹤0.01%	2958
2019 Q2	$582K	Buy	+35,246	New	+$576K	﹤0.01%	2956

Nuveen's CBMG Position: Q1 2021 in Review

Nuveen sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 39,571 shares — an estimated $728K sold.

Nuveen first reported a position in CBMG in Q2 2019 and held it in 7 quarters. The position peaked at $728K in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

Nuveen reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
Nuveen sold 39,571 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $728K.
Nuveen first reported a position in Cellular Biomedicine Group, Inc. in Q2 2019 and held it in 7 quarters.
Nuveen's Cellular Biomedicine Group, Inc. position peaked at $728K in Q4 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Nuveen's 13F filing for Q1 2021, filed 17 May 2021.